title: Update on adult attention-deficit/hyperactivity disorder.
abstract: Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent and highly morbid neurobehavioral disorder afflicting children, adolescents, and adults throughout the world. This article discusses the clinical assessment of adult ADHD, reviews the results of recent adult ADHD treatment studies with an emphasis on medications currently approved by the US Food and Drug Administration, and discusses the clinical management and monitoring of ADHD pharmacotherapy.
authors.affiliation: Clinical and Research Program in Pediatric Psychopharmacology, 185 Alewife Brook Parkway, Suite 2000, Cambridge, MA 02138, USA. phammerness@partners.org
authors.forename: Paul
authors.initials: P
authors.lastname: Hammerness
authors.forename: Craig
authors.initials: C
authors.lastname: Surman
authors.forename: Katherine
authors.initials: K
authors.lastname: Miller
mesh_terms: D000293:Adolescent; D000328:Adult; D000662:Amphetamines / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology*; D002318:Cardiovascular Diseases / Q000139:chemically induced; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D015897:Comorbidity; D005260:Female; D006801:Humans; D008297:Male
chemical_list: C090411:Adderall; D000662:Amphetamines; D000697:Central Nervous System Stimulants